Cargando…

The Impact of Treatment for Smoking on Breast Cancer Patients’ Survival

SIMPLE SUMMARY: This was a retrospective analysis of breast cancer patients who were self-identified as smokers at diagnosis and who were invited to participate in a comprehensive tobacco treatment program (TP) that provided pharmacotherapy and motivational counseling to quit smoking. Our study show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singareeka Raghavendra, Akshara, Kypriotakis, George, Karam-Hage, Maher, Kim, Seokhun, Jizzini, Mazen, Seoudy, Kareem S., Robinson, Jason D., Barcenas, Carlos H., Cinciripini, Paul M., Tripathy, Debu, Ibrahim, Nuhad K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946483/ https://www.ncbi.nlm.nih.gov/pubmed/35326615 http://dx.doi.org/10.3390/cancers14061464

Ejemplares similares

Association of a Comprehensive Smoking Cessation Program With Smoking Abstinence Among Patients With Cancer
por: Cinciripini, Paul M., et al.
Publicado: (2019)

Incidence and impact of brain metastasis in patients with hereditary BRCA1 or BRCA2 mutated invasive breast cancer
por: Garber, Haven R., et al.
Publicado: (2022)

Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies
por: Mouabbi, Jason A., et al.
Publicado: (2022)

Influencers of the Decision to Undergo Contralateral Prophylactic Mastectomy among Women with Unilateral Breast Cancer
por: Singareeka Raghavendra, Akshara, et al.
Publicado: (2021)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

Survival Outcomes in Patients With Hormone Receptor–Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
por: Mouabbi, Jason A., et al.
Publicado: (2023)

The Effects of Scheduled Smoking Reduction and Precessation Nicotine Replacement Therapy on Smoking Cessation: Randomized Controlled Trial With Compliance
por: Cinciripini, Paul M, et al.
Publicado: (2023)

Patterns of Tobacco Product Use and Correlates Among Adults in the Population Assessment of Tobacco and Health (PATH) Study: A Latent Class Analysis
por: Kypriotakis, George, et al.
Publicado: (2018)

Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
por: Barcenas, Carlos H., et al.
Publicado: (2021)

The Late Positive Potentials Evoked by Cigarette-Related and Emotional Images Show no Gender Differences in Smokers
por: Stevens, Elise M., et al.
Publicado: (2019)

Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practice
por: Murthy, Rashmi K., et al.
Publicado: (2020)

SARS-CoV-2 and Anti-Cardiolipin Antibodies
por: Jizzini, Mazen, et al.
Publicado: (2020)

LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS
por: Trevino, Christopher R, et al.
Publicado: (2019)

Behavioral Economic Assessment of Alcohol and Cigarette Demand in Smokers With Alcohol Use Disorder
por: Cui, Yong, et al.
Publicado: (2021)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
por: Vijayaraghavan, Smruthi, et al.
Publicado: (2017)

Outcomes of changing systemic therapy in patients with relapsed breast cancer and 1 to 3 brain metastases
por: Alhalabi, Omar, et al.
Publicado: (2021)

ODP563 Breast Cancer With Liver Metastasis Responds Poorly to Fulvestrant-Based Combination Therapy and Chemotherapy
por: Chien, Christine, et al.
Publicado: (2022)

Central nervous system miliary metastasis in breast cancer: a case series analysis and proposed identification criteria of a rare metastasis subtype
por: Bashour, Sami I., et al.
Publicado: (2020)

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
por: Liu, Shuying, et al.
Publicado: (2023)

You Don't Need an App—Conducting Mobile Smoking Research Using a Qualtrics-Based Approach
por: Cui, Yong, et al.
Publicado: (2022)

Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment
por: Liu, Shuying, et al.
Publicado: (2023)

The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers
por: Robinson, Jason D., et al.
Publicado: (2013)

A tele-mentoring tobacco cessation case consultation and education model for healthcare providers in community mental health centers
por: Cofta-Woerpel, Ludmila, et al.
Publicado: (2018)

Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
por: Fujii, Takeo, et al.
Publicado: (2017)

HER2 status and breast cancer therapy: recent advances
por: Tripathy, Debu
Publicado: (2009)

The BMC Medicine breast cancer collection: an illustration of contemporary research and clinical care
por: Tripathy, Debu
Publicado: (2015)

Individual differences in late positive potential amplitude and theta power predict cue-induced eating
por: Gibney, Kyla D., et al.
Publicado: (2023)

Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors
por: Sinha, Arup K., et al.
Publicado: (2017)

Memantine for the Treatment of Behavioral Disturbance in Unspecified Major Neurocognitive Disorder
por: Terry, Peyton H, et al.
Publicado: (2021)

Ixabepilone development across the breast cancer continuum: a paradigm shift
por: Ibrahim, Nuhad K
Publicado: (2010)

Ixabepilone: Overview of Effectiveness, Safety, and Tolerability in Metastatic Breast Cancer
por: Ibrahim, Nuhad K.
Publicado: (2021)

A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
por: Lim, Bora, et al.
Publicado: (2019)

Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking
por: Tyndale, Rachel F., et al.
Publicado: (2015)

Effect of neoadjuvant chemotherapy regimen on relapse-free survival among patients with breast cancer achieving a pathologic complete response: an early step in the de-escalation of neoadjuvant chemotherapy
por: Weiss, Anna, et al.
Publicado: (2018)

Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy
por: Truong, Van Thi Thanh, et al.
Publicado: (2023)

Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial
por: Yammine, Luba, et al.
Publicado: (2018)

A Randomized Placebo-Controlled Trial of Varenicline for Smoking Cessation Allowing Flexible Quit Dates
por: Rennard, Stephen, et al.
Publicado: (2012)

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer
por: Ueno, Naoto T., et al.
Publicado: (2019)

Subjective social status predicts long-term smoking abstinence
por: Reitzel, Lorraine R, et al.
Publicado: (2011)

Polysubstance use and its correlation with psychosocial and health risk behaviours among more than 95,000 Norwegian adolescents during the COVID-19 pandemic (January to May 2021): a latent profile analysis
por: Rodríguez-Cano, Rubén, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6oem776r10nmj8gfmemvbtqvap